Olumiant (baricitinib) 4 mg film-coated tablets, 14 tablets (Eli Lilly) — listed as Unamity/Olumiyant Treatment of active rheumatoid arthritis. Drug delivery from Europe, compliant with storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.
Indications for the active ingredients of Olumiant™
Treatment of moderate to severe active rheumatoid arthritis in adult patients intolerant to or inadequately responding to one or more disease-modifying antirheumatic drugs.
Orally. The recommended dose is 4 mg once daily.
- Trade Name:Unamiti
- Chemical Name:Baricitinib
- Dosage:4 mg
- Quantity:14
- Form of Issue:Tablets
No reviews yet